Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers
Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients
Distinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells
Tamoxifen alleviates hepatitis C virus-induced inhibition of both toll-like receptor 7 and JAK-STAT signalling pathways in PBMCs of infected Egyptian females
The conserved lysine 151 of HCV NS5B modulates viral genome replication and infectious virus production
IL28B genetic variation and hepatitis C virus–specific CD4+ T-cell responses in anti-HCV-positive blood donors
T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO
Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection